Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Surely it is too late for a randomised controlled trial
| The first 150 words of the full text of this article appear below. |
EDITOR
Rigorous evaluation of surgical procedures is important. The
comparative outcomes and clinical profiles in transplantation (COCPIT)
study, reported by Deng et al, called for a randomised controlled trial
of heart transplantation based on comparing postoperative and waiting
list survival in a single year in Germany.1
The German registry's 12 month postoperative survival rate of 71% was considerably lower that that of patients at Papworth Hospital in Cambridge who have undergone transplantation since 1990 (83%) and that reported by the International Society for Heart and Lung Transplantation (82% for patients who have undergone transplantation since 1995).2 This brings into question the generalisability of the results beyond Germany. Moreover, 12 month follow up is inadequate, as risks after transplantation are greatest in the first year. The risks from end stage heart failure are cumulative.
Deng et al claim that some patients listed to receive transplants are
not sick enough to derive survival benefit